Bladena APS – Trademark Portfolio

Entity Type: 99

Bladena APS holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. The portfolio also extends into Class 7 (Machinery) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include BLADENA and D-STRING. The owner is based in Ringsted.

Sct. Hansgade 9

Ringsted 4100 , DK

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Bladena APS's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (3 filings)

Scientific and technological services; industrial analysis and research services

7
Machinery (3 filings)

Machines and machine tools; motors and engines; machine coupling and transmission components

37
Building & Construction (2 filings)

Building construction; repair; installation services

Frequently Asked Questions

How many trademarks does Bladena APS have?

Bladena APS has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 cancelled.

What trademark classes does Bladena APS file in?

Bladena APS files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 7 (Machinery), Class 37 (Building & Construction). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Bladena APS's most well-known trademarks?

Bladena APS's registered trademark portfolio includes well-known marks such as BLADENA and D-STRING. These are among 2 currently registered trademarks in the portfolio.

What is Bladena APS's trademark registration success rate?

Bladena APS has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.